Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa.


Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Dec 2021
Historique:
accepted: 12 05 2021
pubmed: 20 5 2021
medline: 23 11 2021
entrez: 19 5 2021
Statut: ppublish

Résumé

The monthly dapivirine vaginal ring has proven efficacious in reducing HIV incidence in two Phase 3 clinical trials. When considering the potential future availability of the ring to the public, key questions remain about the feasibility of integrating the ring as an HIV prevention intervention into women's lives. We conducted qualitative mapping interviews (n = 66) among women enrolled in MTN-025/HOPE, an open-label trial conducted in Malawi, South Africa, Uganda and Zimbabwe, to examine how home environments influenced use of the dapivirine vaginal ring. Most women had secure places to store their rings including wardrobes, suitcases, and bags. The primary concerns for ring storage were potential tampering from children or rodents. Household overcrowding limited the privacy some women had which made removal and insertion of vaginal rings challenging. Despite these challenges, ring storage, insertion, and removal was feasible across social and living contexts.

Identifiants

pubmed: 34009480
doi: 10.1007/s10461-021-03311-y
pii: 10.1007/s10461-021-03311-y
pmc: PMC8602444
mid: NIHMS1740627
doi:

Substances chimiques

Anti-HIV Agents 0
Pyrimidines 0
Dapivirine TCN4MG2VXS

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3847-3857

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI069423
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068633
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI068633
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068615
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI106707
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069463
Pays : United States
Organisme : National Institute on Allergy and Infectious Diseases
ID : UM1AI068633, UM1AI068615, UM1AI106707
Organisme : NIAID NIH HHS
ID : UM1 AI069469
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069530
Pays : United States

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Curr HIV/AIDS Rep. 2018 Apr;15(2):190-197
pubmed: 29460223
AIDS Behav. 2020 Dec;24(12):3376-3384
pubmed: 32405725
AIDS. 2018 Jul 17;32(11):1517-1525
pubmed: 29957723
PLoS One. 2019 Nov 8;14(11):e0224898
pubmed: 31703094
N Engl J Med. 2016 Dec;375(22):2133-2143
pubmed: 27959766
J Int AIDS Soc. 2018 Mar;21(3):e25094
pubmed: 29600595
J Int AIDS Soc. 2020 Mar;23(3):e25463
pubmed: 32144874
AIDS Behav. 2020 Jul;24(7):2149-2162
pubmed: 31955361
Lancet HIV. 2021 Feb;8(2):e87-e95
pubmed: 33539762
Int J Womens Health. 2019 Feb 07;11:97-107
pubmed: 30799959
AIDS Behav. 2018 Nov;22(11):3692-3704
pubmed: 29909589
Oncol Nurs Forum. 2014 Sep;41(5):545-7
pubmed: 25158659
AIDS Behav. 2011 Jul;15(5):959-69
pubmed: 20844946
AIDS Behav. 2020 Mar;24(3):866-880
pubmed: 31111297
N Engl J Med. 2016 Dec;375(22):2121-2132
pubmed: 26900902
PLoS One. 2015 Aug 14;10(8):e0135650
pubmed: 26275057
BMC Public Health. 2017 Mar 9;17(1):238
pubmed: 28274219
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21635
pubmed: 28770591
AIDS Behav. 2020 May;24(5):1432-1442
pubmed: 31667678
J Int AIDS Soc. 2014 Sep 08;17(3 Suppl 2):19146
pubmed: 25224610
Cult Health Sex. 2019 Nov;21(11):1209-1224
pubmed: 30657023
AIDS. 2017 May 15;31(8):1159-1167
pubmed: 28441175
AIDS Behav. 2017 May;21(5):1361-1375
pubmed: 27317411

Auteurs

Margaret W Gichane (MW)

Substance Use Gender, and Applied Research Group, RTI International, Research Triangle Park, Durham, NC, USA.

Ariana W K Katz (AWK)

Women's Global Health Imperative, RTI International, Berkley, CA, USA. awkatz@rti.org.

Kenneth Ngure (K)

Department of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.

Rachel Scheckter (R)

FHI 360, Durham, NC, USA.

Kubashni Woeber (K)

South African Medical Research Council, Durban, Kwazulu Natal, South Africa.

Krishnaveni Reddy (K)

Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.

Thelma Tauya (T)

University of Zimbabwe College of Health Sciences Clinical Trials Unit, Harare, Zimbabwe.

Chifundo Zimba (C)

UNC Project Malawi, Lilongwe, Malawi.

Juliane Etima (J)

Makerere University - Johns Hopkins University, Research Collaboration, Kampala, Uganda.

Nomvuyo Mangxilana (N)

Desmond Tutu HIV Foundation, University of Cape Town, Cape Town, South Africa.

Thesla Palanee-Phillips (T)

Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa.

Ariane van der Straten (A)

Women's Global Health Imperative, RTI International, Berkley, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH